UNITED STATES of America, Plaintiff-Appellant, v. Douglas V. DECINCES, Defendant-Appellee, David Parker; F. Scott Jackson; Roger Wittenbach; James Mazzo, Defendants. United States of America, Plaintiff-Appellee, v. James V. Mazzo, Defendant-Appellant.
Nos. 15-50033, 15-50058
United States Court of Appeals, Ninth Circuit
Filed Dec. 22, 2015
808 F.3d 785
Argued and Submitted Sept. 1, 2015.
Richard Marmaro, Douglas A. Smith, Skadden, Arps, Slate Meagher & Flom LLP, Los Angeles, California; Clifford M. Sloan (argued), Michael A. McIntosh, Skadden, Arps, Slate, Meagher & Flom LLP, Washington, D.C., for Defendant-Appellee/Defendant-Appellant James Mazzo.
Kenneth B. Julian (argued), Arunabha Bhoumik, Andrea Ruth Bird, and Garrett Mott, Manatt, Phelps, & Phillips, LLP, Costa Mesa, CA, for Defendant-Appellee Douglas DeCinces.
Before: SUSAN P. GRABER, JOHNNIE B. RAWLINSON, and PAUL J. WATFORD, Circuit Judges.
Opinion by Judge RAWLINSON; Concurrence by Judge WATFORD.
OPINION
RAWLINSON, Circuit Judge:
This case presents two appeals, one from the government and one from Defendant-Appellant James Mazzo (Mazzo). In Appeal No. 15-50033, the government appeals the district court‘s pretrial order granting motions in limine to exclude certain pieces of evidence in a case in which Douglas DeCinces (DeCinces), Mazzo, and others were charged with insider-trading offenses relating to the stock of Advanced Medical Optics, Inc.
Appeal No. 15-50058 is Mazzo‘s cross-appeal challenging the district court‘s order denying his motion to dismiss a securities fraud charge under
I. BACKGROUND
The government‘s original indictment charged DeCinces, F. Scott Jackson (Jackson), and other defendants, not including Mazzo, with insider trading and money laundering. The grand jury also returned a First Superseding Indictment and a Second Superseding Indictment that became the operative charging document, and added Mazzo as a defendant.
The Second Superseding Indictment alleged that Mazzo and DeCinces participated in a scheme to defraud Mazzo‘s company, Advanced Medical Optics, Inc. (EYE),1 and its shareholders. See id. According to the Second Superseding Indictment, as President, Chief Executive Officer, and Chairman of the Board of Directors of EYE, Mazzo had access to material, non-public information about EYE‘s forthcoming merger and acquisition activities, which he shared with DeCinces in violation of a duty of trust and confidence to EYE and for a personal benefit.
The government intimated, although it did not charge in the indictment, that Mazzo also tipped DeCinces in the summer of 2007 about EYE‘s attempt to acquire Bausch and Lomb. The government asserted that DeCinces sold $250,000 of EYE stock and purchased Bausch and Lomb stock mere hours before EYE publicly announced that it had submitted a proposal to buy Bausch and Lomb.
The Second Superseding Indictment also alleged that, in late 2008 and early 2009, Mazzo tipped DeCinces that EYE would be acquired by Abbot Laboratories, and that DeCinces thereafter liquidated his diversified stock portfolio, invested the proceeds in EYE stock, and shared non-public information about the impending acquisition with several other people, urging them to purchase EYE stock. After the Abbott acquisition, DeCinces sold his shares of EYE stock, realizing a profit of approximately $1.3 million.
DeCinces moved to strike the IntraLase allegations from the Second Superseding Indictment as prejudicial surplusage and as time-barred. The district court denied the motion, ruling that “the [2006 and 2007 IntraLase] allegations can show a common scheme, lack of mistake, or intent to defraud in the alleged 2008 and 2009 actions when viewing the contested allegations collectively and comparing them to the 2008 and 2009 actions.” The court further ruled that “[p]art of a section 1348 prosecution includes proving a scheme to defraud and knowing intent by the defendant to do the same. Among other things, the contested factual allegations appear to directly mirror meetings and trades that took place in 2008 and 2009 and provide context for making this comparison.” Accordingly, the district court held that “DeCinces has not shown the contested allegations are ‘irrelevant or immaterial to the charges.‘”
Mazzo and DeCinces subsequently filed motions in limine to exclude evidence involving the IntraLase and Bausch and Lomb transactions as inadmissible “other acts” evidence under Rule 404(b) of the Federal Rules of Evidence, and as evidence that should be excluded under Rule 403. Specifically, DeCinces and Mazzo asserted that admission of the evidence would unduly consume time and require additional mini-trials.
At a hearing on the motions in limine the court gave its tentative ruling, granting the motions in limine to exclude evidence regarding the IntraLase and Bausch and Lomb transactions. The court provided no explanation of the ruling. The minute order memorializing the ruling stated only: “GRANTS the motion [to exclude propensity/other act evidence] without prejudice to asking the Court outside the presence of the jury to consider permitting the introduction of the evidence.”
The government filed a timely notice of appeal, challenging the district court‘s grant of the motions in limine. Mazzo filed a timely cross-appeal.
II. STANDARDS OF REVIEW
We have jurisdiction to determine our jurisdiction. See Allen v. Meyer, 755 F.3d 866, 867 (9th Cir. 2014). We review this question de novo. See United States v. W.R. Grace, 526 F.3d 499, 505 (9th Cir. 2008) (en banc). We review a district court‘s exclusion of evidence for
III. DISCUSSION
Appeal No. 15-50033–Government‘s Interlocutory Appeal of the District Court‘s Order Granting DeCinces’ and Mazzo‘s Motions in Limine
A. We have jurisdiction pursuant to 18 U.S.C. § 3731 to entertain the government‘s interlocutory appeal.
Title
In a criminal case . . . [a]n appeal by the United States shall lie to a court of appeals from a decision or order of a district court suppressing or excluding evidence . . . not made after the defendant has been put in jeopardy and before the verdict or finding on an indictment or information, if the United States attorney certifies2 to the district court that the appeal is not taken for purpose of delay and that the evidence is a substantial proof of a fact material in the proceeding. . . .
(Emphasis Added). DeCinces and Mazzo argue that the district court‘s rulings were tentative and nonfinal, and that we therefore lack jurisdiction to consider the government‘s appeal. We disagree.
First, DeCinces argues that the district court‘s evidentiary ruling was not a “final decision” under
Because evidentiary rulings are by their very nature nonfinal, see Hoffman v. Constr. Protective Servs., Inc., 541 F.3d 1175, 1178 (9th Cir. 2008), as amended, our recognition in W.R. Grace, 526 F.3d at 505, of the government‘s right to appeal a nonfinal evidentiary ruling was a sub silentio reversal of the language in Dior engrafting a finality requirement onto § 3731. See Herzog v. United States, 226 F.2d 561, 567-68 (9th Cir. 1955) (concluding that a sub silentio reversal has occurred when two cases “cannot both be right“). The fact that the district court‘s order was not final under § 1291 does not bar the government‘s interlocutory appeal under § 3731.
Second, Mazzo argues that the district court‘s order granting the motions in limine was insufficiently final even within
In sum, we have jurisdiction to decide the government‘s interlocutory appeal.
B. The district court abused its discretion when it granted the motions in limine excluding the IntraLase and Bausch and Lomb evidence.
As an initial matter, we note that the district court did not elucidate from the bench or in its subsequent order the reasoning behind its grant of the motions in limine.3 In particular, the district court did not indicate whether it was excluding the evidence under Rule 403, Rule 404, or both. We conclude that, although this evidence was “other acts” evidence within the meaning of Rule 404(b), it was admissible under Rule 404(b) to show intent, plan, knowledge, or lack of mistake. We also conclude that, taken as a whole, the evidence was not categorically inadmissible under Rule 403.
We consider first whether the evidence should have been excluded under Rule 404. That rule provides in pertinent part:
1) Prohibited Uses. Evidence of a crime, wrong, or other act is not admissible to prove a person‘s character in order to show that on a particular occasion the person acted in accordance with the character.
2) Permitted Uses . . . This evidence may be admissible for another purpose, such as proving motive, opportunity, intent, preparation, plan, knowledge, identity, absence of mistake, or lack of accident. . . .
At a minimum, evidence of the IntraLase and Bausch and Lomb transactions was admissible to prove intent, plan, knowledge or absence of mistake. See United States v. Ramos-Atondo, 732 F.3d 1113, 1122-24 (9th Cir. 2013). It appears that the district court at one point recognized the relevance of this very evidence. When DeCinces moved to strike the IntraLase allegations from the indictment, the district court denied the motion on the basis that the IntraLase allegations could “show a common scheme, lack of mistake, or intent to defraud.”
The excluded evidence reflects DeCinces’ investment history and pattern of
The excluded evidence satisfies the other predicates for admissibility delineated in United States v. Bailey, 696 F.3d 794, 799 (9th Cir. 2012). In that case, we concluded that other act evidence is admissible if:
(1) the evidence tends to prove a material point; (2) the other act is not too remote in time; (3) the evidence is sufficient to support a finding that defendant committed the other act; and (4) (in certain cases) the act is similar to the offense charged.
Id. (citation omitted).
First, the IntraLase and Bausch and Lomb evidence is material. As the district court recognized, this evidence tends to prove a common scheme and a lack of mistake or coincidence.
Second, these prior acts were not too remote in time. The indictment spans a two-and-a-half year time frame from October, 2006 to January, 2009. The IntraLase transactions occurred from December, 2006 to February, 2007, and the Bausch and Lomb transactions were in July, 2007, both within the timespan covered by the indictment. See United States v. Lozano, 623 F.3d 1055, 1059-60 (9th Cir. 2010) (per curiam) (concluding that three years was not too remote).
Third, the IntraLase and Bausch and Lomb evidence is sufficient to support a determination that Mazzo and DeCinces engaged in insider trading, given Mazzo‘s access to insider information and the temporal and tipper/tippee/company connections. See, e.g., United States v. Salman, 792 F.3d 1087, 1092 (9th Cir. 2015) (sustaining a conviction for insider trading where the tipper and tippee both benefitted from disclosure of insider information).
Finally, these acts not only are similar, but are essentially the same as the charged conduct. Having met these predicates, the IntraLase and Bausch and Lomb evidence was relevant and admissible under Rule 404(b). To the extent the district court concluded otherwise, it abused its discretion. See Tapley, 728 F.3d at 1139.
Nor was the evidence properly excluded under Rule 403. See United States v. Cruz-Garcia, 344 F.3d 951, 956 (9th Cir. 2003). Because the district court conducted no balancing under Rule 403, we review the exclusion of evidence de novo. See United States v. Moran, 493 F.3d 1002, 1012 (9th Cir. 2007), as amended. The evidence is highly probative. As discussed above, the evidence tends to support the government‘s allegations about the defendants’ intent, plan, knowledge, or lack of mistake. In particular, the evidence tends to support the government‘s allegations that DeCinces’ and the other trading defendants’ purchases of EYE stock were the product of a scheme to trade on nonpublic information obtained from EYE, not mere good luck. The evidence is also relevant to showing the defendants’ respective roles in the alleged scheme. Although the admission of the evidence may harm the defendants’ case, that is not reason to exclude it under Rule 403, which refers only to unfair prejudice. See United States v. Bowen, 857 F.2d 1337, 1341 (9th Cir. 1988). Similarly, the admission of any evidence will necessarily lengthen the trial, but we cannot conclude
We conclude that, taken as a whole, the IntraLase and Bausch and Lomb evidence is admissible under Rule 403. We therefore reverse the district court‘s order granting the defendants’ motions to exclude this evidence. The district court may impose appropriate limits on the government‘s presentation of this evidence, should developments at trial warrant doing so.
Appeal No. 15-50058-Mazzo‘s Interlocutory Appeal of the District Court‘s Denial of His Motion to Dismiss the Indictment.
A. We lack pendent appellate jurisdiction over Mazzo‘s interlocutory appeal.
Mazzo seeks to challenge the district court‘s order denying his motion to dismiss the portion of the indictment alleging securities fraud in violation of
We have determined that pendent appellate jurisdiction is the exercise of jurisdiction over issues that ordinarily may not be reviewed on interlocutory appeal, but may be reviewed on interlocutory appeal if raised in conjunction with other issues properly before the court and if the rulings were inextricably intertwined or if review of the pendent issue was necessary to ensure meaningful review of the independently reviewable issue. . . .
United States v. Tillman, 756 F.3d 1144, 1149 (9th Cir. 2014) (citation, alteration, and internal quotation marks omitted).
Because Mazzo‘s appeal of the denial of the motion to dismiss is not “inextricably intertwined” with the government‘s interlocutory appeal as envisioned in Tillman, we have no pendent jurisdiction over this issue.4 Id. Unsurprisingly, the exercise of pendent appellate jurisdiction is a rare event. See id.
We have emphasized that what issues qualify as inextricably intertwined should be interpreted “very narrowly.” Id. Indeed, issues resting upon “common facts” do not necessarily qualify for pendent appellate jurisdiction. Cunningham v. Gates, 229 F.3d 1271, 1285 (9th Cir. 2000), as amended (citation omitted). Rather, the issues must rely on legal theories that are “so intertwined that we must decide the pendent issue in order to review the claims properly raised on interlocutory appeal,” or “resolution of the issue properly raised on interlocutory appeal [must] necessarily resolve[] the pendent issue.” Id. (citations omitted). Neither circumstance is presented in this case, as the evidentiary issues raised by the government‘s appeal are largely distinct from those concerning the scope and application of
B. We lack jurisdiction over Mazzo‘s interlocutory appeal under the collateral order doctrine.
Mazzo also argues that we have jurisdiction under the collateral order doctrine, which permits appellate review of a “small class” of cases that “finally determine[] claims of right separable from, and collateral to, rights asserted in the action, too important to be denied review and too independent of the cause itself to require that appellate consideration be deferred until the whole case is adjudicated.” Cohen v. Beneficial Indus. Loan Corp., 337 U.S. 541, 546 (1949). As we have explained, the collateral order doctrine applies only if: 1) the collateral order conclusively resolved the disputed question; 2) review will resolve an important issue that is completely separate from the merits of the action; and 3) the issue will essentially be unreviewable on appeal from a final judgment. See Tillman, 756 F.3d at 1149.
Mazzo contends that he has asserted a “colorable” double jeopardy claim, which renders this matter immediately reviewable under the collateral order doctrine. United States v. Lewis, 368 F.3d 1102, 1107 (9th Cir. 2004). Mazzo‘s double jeopardy claim is premised on the theory that inclusion in the indictment of a charge under
We assume, for purposes of decision, that Mazzo‘s double jeopardy claim is colorable and that the first two prongs of the collateral order doctrine are satisfied; nevertheless, his claim flounders on the third prong—reviewability following judgment. See Tillman, 756 F.3d at 1149 (noting that the collateral order doctrine is inapplicable where a direct appeal is available). Mazzo has not disputed his entitlement to a direct appeal should he be convicted of violations of both § 1348 and Rule 10b-5. See id. He argues, rather, that a direct appeal is insufficient because the Double Jeopardy Clause protects him against the trial itself. But that principle does not apply when, as here, the issue is whether multiplicitous punishment would be allowed for charges that—regardless of the double jeopardy claim—may be tried. See United States v. Schales, 546 F.3d 965, 978 (9th Cir. 2008) (“The Double Jeopardy Clause does not, of course, prohibit the government from prosecuting a defendant for multiple offenses in a single prosecution.“) (citing Ohio v. Johnson, 467 U.S. 493, 500 (1984)). For these reasons, Mazzo cannot establish jurisdiction under the collateral order doctrine.
Because we have neither pendent appellate jurisdiction nor collateral order jurisdiction, we must dismiss Mazzo‘s cross-appeal. See In re Application for Exemption from Elec. Pub. Access Fees, 728 F.3d 1033, 1041 (9th Cir. 2013).
IV. CONCLUSION
Title
We lack jurisdiction over Mazzo‘s cross-appeal. There is neither pendent appellate jurisdiction nor jurisdiction under the collateral order doctrine. Consequently, Mazzo‘s appeal must be dismissed.
No. 15-50033-The district court‘s grant of the defendants’ motions in limine is REVERSED.
No. 15-50058-Mazzo‘s appeal from the district court‘s order denying his motion to dismiss is DISMISSED for lack of jurisdiction.
WATFORD, Circuit Judge, concurring:
I agree that we lack jurisdiction over Mazzo‘s cross-appeal under the collateral order doctrine. Mazzo may invoke the doctrine only if he has a “colorable” claim under the Double Jeopardy Clause. United States v. Alvarez-Moreno, 657 F.3d 896, 899 (9th Cir. 2011). He has no such claim—at least not right now. He contends only that the Rule 10b-5 and
